Mylan Laboratories has announced plans to acquire Matrix Laboratories Ltd. for approximately $736 million. Under the terms of the transaction, Mylan will purchase 51.5% of Matrix’s shares outstanding under an agreement with certain selling shareholders and will make an “open offer” to Matrix’s remaining shareholders to acquire as much as 20% more of Matrix’s shares outstanding. Matrix will remain a publicly traded company in India and will continue to operate on an ...